Company intelligence / Profile preview
HCW Biologics
Miramar, Florida, United Statesinvestors.hcwbiologics.com ↗
- Ownership
- Public · HCWB
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
HCW Biologics has developed two proprietary drug discovery platforms generating multi-functional fusion proteins targeting immune modulation. Lead asset HCW9218 has shown early safety and activity signals in solid tumor patients refractory to chemotherapy. The company’s pipeline includes additional candidates targeting regulatory T cell expansion and immune stimulation. Clinical data are still emerging from ongoing early-phase trials.
- Therapeutic areas
- OncologyImmunologyCardiovascular
- Modalities
- Multi-functional fusion proteins (immunotherapies)Protein-based therapeuticsAntibody therapiesImmune cell engagers and stimulators
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →03
Partnerships
WY Biotech—license agreement on a Class I immunotherapeutic product candidate combining multiple immune functional domains on a novel scaffold platform.University of Minnesota Masonic Cancer Center—investigator-sponsored trial of HCW9218 in solid tumors.University of Pittsburgh Medical Center—investigator-sponsored trial of HCW9218 in ovarian cancer.
04
Financials
- Market cap
- $844.8K
- Total revenue
- $135.6K
- Enterprise value
- $6.7M
Beyond the preview
Go deeper on HCW Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HCW Biologics.